It is amazing when you meet someone and they find out you are a nurse (infusion nurse), they start asking a lot of health related questions. Honestly, I don’t mind and I am grateful that most people I meet know what “infusion therapy” is, although a few are still confused that it means…blood draw!! 😦…
I am not sure why I am always surprised to see that the all time top read post here is the one about avoiding the antecubital fossa when starting a peripheral IV….“Just say No” Ok, so I am really grateful that many are reading my blog but I am also a bit concerned that perhaps…
It doesn’t take a rocket scientist to know that when you don’t have enough of a good thing, bad things can happen. This is the case with the on-going drug shortages and the resulting potential issues that affect the care we provide and patient safety concerns. The ISMP (Institute for Safe Medication Practices) recently released…
Certain lots of Epogen and Procrit (Epoetin alfa) vials are being recalled as a precaution, because the vials may contain extremely thin glass flakes (lamellae) that are barely visible. The potential serious adverse events resulting from the use of a sterile injectable product with particulates by the intravenous route include embolic, thrombotic and other vascular…
There is an FDA Class I recall of Symbig Infusion Pumps One channel, model 16026 and Dual channels, model 16027 made by Hospira due to the potential for unrestricted flow of fluid or medication if the administration set (cassette) is removed before the cassette carriage fully opens and the slide/roller clamp is not closed. Additionally,…
There is no doubt that several chemotherapeutic agents have vesicant properties, and when inadvertently infused into the surrounding tissue from an infiltrated IV, these agents may have the potential to cause blisters, severe tissue injury or necrosis, known as extravasation. The damage to the tissue can occur from direct contact with the vesicant medication, from…
The National Institute of Occupational Safety and Health (NIOSH) released an update to the 2004 sample list of hazardous drugs. The 2010 list supersedes the 2004 list and includes 21 additional drugs. According to ASHP [1990] the definition of hazardous drugs:1. Carcinogenicity 2. Teratogenicity or other developmental toxicity 3. Reproductive toxicity4. Organ toxicity at low…
“ we’re just like a filling station, they (patients) come here, we fill them up and let them go”!! This was the response from several RN’s working in a hospital based outpatient infusion center I recently visited where chemotherapy and biologic agents are administered to patients with oncologic and non-oncologic disorders, including patient’s with immune…
Nimodipine is a medication intended to be given in a critical care setting to treat neurologic complications from subarachnoid hemorrhage and is only available as a capsule. The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals that nimodipine capsules should be given ONLY by mouth or through a feeding tube (nasogastric tube). This…
On July 13, 2010, the U.S. Food and Drug Administration required Baxter Healthcare Corp. to take specific steps to carry out the April 2010 recall of all Colleague Volumetric Infusion Pumps (CVIP) and to provide customers with a refund, a replacement pump, or lease termination. According to the FDA, it is requiring Baxter to provide…
Infusion Nurse Blog 